DD296933A5 - Peptide - Google Patents

Peptide Download PDF

Info

Publication number
DD296933A5
DD296933A5 DD90338488A DD33848890A DD296933A5 DD 296933 A5 DD296933 A5 DD 296933A5 DD 90338488 A DD90338488 A DD 90338488A DD 33848890 A DD33848890 A DD 33848890A DD 296933 A5 DD296933 A5 DD 296933A5
Authority
DD
German Democratic Republic
Prior art keywords
insulin
glycosylated
phe
human insulin
human
Prior art date
Application number
DD90338488A
Other languages
German (de)
English (en)
Inventor
John B Halstrom
Original Assignee
����`�������@�a�k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`�������@�a�k�� filed Critical ����`�������@�a�k��
Publication of DD296933A5 publication Critical patent/DD296933A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DD90338488A 1989-03-08 1990-03-07 Peptide DD296933A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK111489A DK111489D0 (da) 1989-03-08 1989-03-08 Peptider

Publications (1)

Publication Number Publication Date
DD296933A5 true DD296933A5 (de) 1991-12-19

Family

ID=8101165

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90338488A DD296933A5 (de) 1989-03-08 1990-03-07 Peptide

Country Status (19)

Country Link
EP (1) EP0462192A1 (cs)
JP (1) JPH04504117A (cs)
KR (1) KR920701249A (cs)
CN (1) CN1045586A (cs)
AU (1) AU638701B2 (cs)
CA (1) CA2049937A1 (cs)
CS (1) CS114290A3 (cs)
DD (1) DD296933A5 (cs)
DK (1) DK111489D0 (cs)
FI (1) FI914226A7 (cs)
GR (1) GR1000604B (cs)
HU (1) HUT59942A (cs)
IL (1) IL93674A0 (cs)
NO (1) NO913517L (cs)
NZ (1) NZ232808A (cs)
PT (1) PT93366A (cs)
WO (1) WO1990010645A1 (cs)
YU (1) YU45490A (cs)
ZA (1) ZA901737B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2642214T3 (es) 2004-01-21 2017-11-15 Novo Nordisk Health Care Ag Conjugación de péptidos mediante transglutaminasa
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2010088268A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Exogenously triggered controlled release materials and uses thereof
WO2010088300A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Crystalline insulin-conjugates
BRPI1007457A2 (pt) 2009-01-28 2015-08-25 Smartcells Inc Conjungado, formulação de liberação prolongada, e, sistema de distribuição de bomba.
WO2010107520A1 (en) 2009-03-20 2010-09-23 Smartcells, Inc. Soluble non-depot insulin conjugates and uses thereof
US8623345B2 (en) 2009-03-20 2014-01-07 Smartcells Terminally-functionalized conjugates and uses thereof
EP2598522A4 (en) 2010-07-28 2014-11-12 Smartcells Inc RECOMBINANT LKTINE, BINDING POINT MODIFIED LECTIN AND APPLICATIONS THEREOF
AU2011282977A1 (en) 2010-07-28 2013-02-21 Smartcells, Inc. Drug-ligand conjugates, synthesis thereof, and intermediates thereto
JP2013535467A (ja) 2010-07-28 2013-09-12 スマートセルズ・インコーポレイテツド 組換えにより発現されたインスリンポリペプチドおよびその使用
US9624287B2 (en) 2012-07-17 2017-04-18 Case Western Reserve University O-linked carbohydrate-modified insulin analogues
EP2877200B1 (en) * 2012-07-17 2019-05-08 Case Western Reserve University O-linked carbohydrate-modified insulin analogues
CN104902922B (zh) 2012-11-13 2017-12-12 阿道恰公司 包含经取代阴离子化合物的速效胰岛素制剂
US9707276B2 (en) 2012-12-03 2017-07-18 Merck Sharp & Dohme Corp. O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
WO2014160185A2 (en) 2013-03-14 2014-10-02 The Board Of Trustees Of The Leland Stanford Junior University Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
KR20160065930A (ko) 2013-10-04 2016-06-09 머크 샤프 앤드 돔 코포레이션 글루코스-반응성 인슐린 접합체
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
CN105597080A (zh) * 2016-01-29 2016-05-25 程潜 一种用于治疗尿毒症和尿蛋白的药物
CN105535927A (zh) * 2016-01-29 2016-05-04 山东中海制药有限公司 一种用于治疗流感、上呼吸道感染、病毒性肺炎的药物
CN105709207A (zh) * 2016-01-29 2016-06-29 徐宝贞 一种用于治疗痛风的药物
CA3025988A1 (en) 2016-06-02 2017-12-07 Sanofi Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3847890A (en) * 1971-11-01 1974-11-12 A Green Acidic monosaccharide-substituted proteins
US4444683A (en) * 1982-11-17 1984-04-24 University Of Utah Glycosylated insulin derivatives
EP0119650A3 (en) * 1983-03-21 1987-09-30 THE PROCTER & GAMBLE COMPANY Galactosyl-insulin conjugates useful in treating diabetics
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.

Also Published As

Publication number Publication date
JPH04504117A (ja) 1992-07-23
HU902787D0 (en) 1991-11-28
HUT59942A (en) 1992-07-28
NZ232808A (en) 1992-04-28
PT93366A (pt) 1990-11-07
NO913517D0 (no) 1991-09-06
GR900100159A (en) 1990-07-31
GR1000604B (el) 1992-08-26
WO1990010645A1 (en) 1990-09-20
NO913517L (no) 1991-11-06
EP0462192A1 (en) 1991-12-27
AU638701B2 (en) 1993-07-08
FI914226A0 (fi) 1991-09-06
CA2049937A1 (en) 1990-09-09
KR920701249A (ko) 1992-08-11
CN1045586A (zh) 1990-09-26
CS114290A3 (en) 1992-02-19
AU5280790A (en) 1990-10-09
ZA901737B (en) 1990-11-28
DK111489D0 (da) 1989-03-08
YU45490A (en) 1991-10-31
FI914226A7 (fi) 1991-09-06
IL93674A0 (en) 1990-12-23

Similar Documents

Publication Publication Date Title
DD296933A5 (de) Peptide
DE69722397T2 (de) Insulin-derivate und ihre verwendung
DE69632224T2 (de) Reduzierung von Gelation von Fettsäureacylierten Proteinen unter Nutzung von Zitratpuffer
DE69224858T2 (de) Essentiell reines menschliches Parathyroidhormon
DE69716905T2 (de) Analoge des glucagon ähnlichen peptides -2
DE3880346T2 (de) Insulinderivate.
DE69736634T2 (de) Antagonisten des intestinotrophen glp-2 peptides
DE3382749T2 (de) Glycosylierte Insulin-Derivate.
EP0167575B1 (de) Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung
DE19908041A1 (de) Kovalent verbrückte Insulindimere
DE69103755T2 (de) Wachstumshormonkristalle und verfahren zu deren herstellung.
DE3326472A1 (de) Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
EP0427162B1 (de) Neue Insulinderivate, Verfahren zu deren Herstellung, ihre Verwendung und eine sie enthaltende pharmazeutische Zubereitung
DE1927209A1 (de) Acyl-substituierte Insuline und Verfahren zu ihrer Herstellung
DE69218222T2 (de) Neue ganglioside-derivaten
DE2204053A1 (de) Insulinderivate
DE3587226T2 (de) Antidiabetikaverbindungen.
DE1940130C2 (de) Verfahren zur Reinigung von Insulin, nach diesem Verfahren gereinigtes Insulin und dessen Verwendung
DE69829953T2 (de) Kristallisation von proteinen
DE3586793T2 (de) Verwendung von vollsynthetischem alpha-hanap.
DE69322882T2 (de) Intrazelluläre inhibitoren der aldose-reduktase
DE68912250T2 (de) Mittel zur Prüfung der Adrenokorkikotrophormone-Sekretion.
DE69724156T2 (de) Aus mycobacterium tuberculosis extrahierter kohlenwasserstoffkomplex und verfahren zu dessen herstellung
DE19543628A1 (de) Humanes, im Blut zirkulierendes Peptid mit insulinotroper Wirkung (GCAP-II-(89-112), (Guanylyl Cyclase C Aktivierendes Peptid II) und seine GCAP-Analoga, insbesondere das GCAP-I-(99-115), seine Anwendung als pharmakologischer Wirkstoff und Benutzung seines Wirkungsprinzipes zur Bereitstellung neuer GC-C-abhängiger insulinotroper Wirkstoffe
DE68928646T2 (de) Natriuretisches hormon

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee